Farmacéuticos Comunitarios. 2016 Jun 30; 8(2):5-15 DOI: 10.5672/FC.2173-9218.(2016/Vol8).002.02

Diabetes in Spain from the perspective of the community pharmacy: knowledge, compliance, and satisfaction with treatment

Fornos-Pérez JA, Ferrer JC, García-Rodríguez P, Huarte-Royo J, Molinero Crespo A, Mera-Gallego R, Vérez-Cotelo N, Andrés-Rodríguez NF.
Fornos-Pérez JA, Ferrer JC, García-Rodríguez P, Huarte-Royo J, Molinero A, Mera-Gallego R, Vérez-Cotelo N, Andrés-Rodríguez NF. La diabetes en España desde la perspectiva de la farmacia comunitaria: conocimiento, cumplimiento y satisfacción con el tratamiento. Farmacéuticos Comunitarios. 2016 Jun 30; 8(2):5-15 DOI: 10.5672/FC.2173-9218.(2016/Vol8).002.02
Abstract : 
Objectives: To know the current situation, in terms of use of medicines, controls, health status and perception they have about their disease Spanish diabetics who come to community pharmacies.
 
Methods: Descriptive cross-sectional study (January to March 2014) in community pharmacies in Spanish. Subjects: people diagnosed diabetes who came to the pharmacy to withdraw his treatment. Data sheet included use of drugs, carrying out regular checks, knowledge about the disease (Berbés) questionnaire, knowledge and compliance with treatment and satisfaction with medication (DTSQ). The minimum sample size was estimated at 385 people with diabetes.
 
Results: 652 diabetic patients, 49.5% men and 50.5% female, 54.6% over the age of 65, 73,0% with two or more cardiovascular risk factors. 84,1% use ADO, 38.0% insulin and 22.9% both. 146 patients had one or more episodes of hypoglycemia in the last year. 65.3% of the patients with insulin, reused needles. He 91.6% appears not to have any problems in the realization of self-analysis and 72.8% reuse lancets. Properly knew his treatment 196 (34.1%) and 432 did it (76.3%). Satisfaction with the treatment is good (24, 6±6, 6 points out of 36) (82.8% of satisfied patients).
 
Conclusions: The use of drugs not fits enough to clinical guidelines. Revisions and the self-monitoring are inadequate. The knowledge about the disease and medication is low. Compliance and satisfaction with treatment is high, lower in insulin users.
 
Article download link: